ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

List of diseases spread by deer tick grows, including malaria-like problems and potentially fatal en...

Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients

Lyme disease confirmed in humans from southern states

Anticancer Properties Of Saffron

Teenager with stroke symptoms actually had Lyme disease

World Famous Joint Relief Formula Enhanced by Modern Science

The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from do...

Autistic and non-autistic brain differences isolated for first time

In a warmer world, ticks that spread disease are arriving earlier, expanding their ranges

The Worst Foods to Eat When You're Sick, and the Best Ones

 
Print Page
Email Article

Simple, Inexpensive Bedside Test Sorts Out Causes of Low Back Pain Faster & Better

  [ 15 votes ]   [ Discuss This Article ]
By Massachusetts General Hospital • www.ProHealth.com • April 20, 2009


“Not only was the 10- to 15-minute StEP assessment able to accurately determine whether or not a participant's back pain was neuropathic, it also was superior to an existing screening test for neuropathic pain and even to MR imaging of the spine…”

A simple and inexpensive method of assessing pain, developed by Massachusetts General Hospital (MGH) researchers, is better than currently used techniques for distinguishing neuropathic pain (pain caused by damage to the nervous system) from other types of chronic back pain.

Being able to more precisely determine the underlying nature of the pain is essential to choosing the best treatment. The report appears in the April 7 issue of the journal PLoS Medicine. [See the free-access article “A novel tool for the assessment of pain: Validation in low back pain,” and 5-page StEP Questionnaire.]

"Currently clinicians measure pain only by asking how bad it is, using scales from mild to moderate to severe or asking patients to rate their pain from 1 to 10," says Joachim Scholz, MD, of the Neural Plasticity Research Group in the MGH Department of Anesthesia and Critical Care, lead author of the study. "This approach misses key characteristics that reflect the mechanisms causing the pain."

Clifford Woolf, MD, PhD, director of the Neural Plasticity Research Group and senior author of the article, adds, "By evaluating individual components of pain, our method allows the creation of a ˜pain fingerprint' for each patient."

In order to identify specific symptoms and signs that could signify underlying pain mechanisms, the investigators first enrolled a group of 187 patients with chronic pain caused by a known condition.

Some patients had neuropathy associated with diabetes or shingles, and others had low back pain with or without evidence of spinal nerve root damage. These participants received an extensive medical history and physical examination, including 23 simple tests that could be conducted at the bedside or in an office visit.

Distinct association patterns of pain-related symptoms and signs allowed the classification of six subgroups of patients with neuropathic pain and two subgroups with nonneuropathic pain.

Based on a detailed analysis of these results, the team developed the Standardized Evaluation of Pain (StEP) - a set of 6 questions and 10 physical tests that best discriminated between neuropathic and nonneuropathic pain.

To test the validity of StEP, they collaborated with researchers from Addenbrooke's Hospital, a teaching hospital of the University of Cambridge in the United Kingdom, who enrolled 137 patients with chronic low back pain. To determine whether or not their pain was neuropathic, patients were evaluated by an interdisciplinary team of two physicians (a neurosurgeon and a rheumatologist) and a physical therapist. Participants then received the StEP assessment from a specially trained investigator not informed of the results of the clinical evaluation.

Not only was the 10- to 15-minute StEP assessment able to accurately determine whether or not a participant's back pain was neuropathic, it also was superior to an existing screening test for neuropathic pain and even to MR imaging of the spine, which can be misleading since many people have visible degeneration of spinal disks with little or no pain.

Scholz explains, "The treatment of neuropathic and nonneuropathic pain is quite different, and if a diagnosis is wrong, patients may receive treatment, including surgery, that does not improve their pain.

"We showed that StEP is a valuable diagnostic tool for low back pain and will conduct further studies to determine the usefulness of our clinical approach in other types of pain. The critical test will be seeing how patients with different subtypes of pain respond to different treatments, something we hope to examine in the very near future."

"There is enormous interest from the Obama administration and the National Institutes of Health in evaluating the efficacy of competing medical treatments," says Woolf. "We compared the sensitivity and precision of different diagnostic tools and produced a low-tech approach that is superior to a standard high-tech imaging approach, showing how evidence-based medicine can both improve the practice of medicine and reduce cost."

By publishing StEP as a supplement to the PLoS Medicine article, the research team is making the assessment broadly available to clinicians.

Source: Massachusetts General Hospital, news release Apr 6, 2009.



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Research treats the fungus among us with nontoxic medicinal compound
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing